The seminar will provide information on deaths related to MDMA in Australia during a period when MDMA markets have undergone substantial changes, with increasing manufacture of high purity MDMA.
Among the 392 deaths identified, the individuals’ characteristics and the circumstances of death will be described.
Both deaths attributed to drug toxicity and those which occurred due to other causes in which MDMA was recorded as a contributory factor are considered.
Dr Julia Lappin, Senior Lecturer
National Drug and Alcohol Research Centre and School of Psychiatry, UNSW
Date and time
Thu 18th Jun 2020, 3:00 pm - 4:00 pm AEST